CPHI vs ICE · rev $4.5M vs P/E 37, rev $12.64B
China Pharma Holdings Inc (CPHI) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported CPHI revenue for 2024-12-31 was $4.5M. Net income was -$4.7M. Revenue was down 35.4% from 2023-12-31 to 2024-12-31. CPHI currently screens at market cap $29.0M.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
CPHI currently screens at market cap $29.0M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the CPHI and ICE stock pages for the full models.
Not investment advice.